IL236524B - Camel antibody libraries - Google Patents
Camel antibody librariesInfo
- Publication number
- IL236524B IL236524B IL236524A IL23652414A IL236524B IL 236524 B IL236524 B IL 236524B IL 236524 A IL236524 A IL 236524A IL 23652414 A IL23652414 A IL 23652414A IL 236524 B IL236524 B IL 236524B
- Authority
- IL
- Israel
- Prior art keywords
- antibody libraries
- camelid antibody
- camelid
- libraries
- antibody
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/005—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/22—Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261695819P | 2012-08-31 | 2012-08-31 | |
| PCT/EP2013/068110 WO2014033304A2 (en) | 2012-08-31 | 2013-09-02 | Highly diverse combinatorial antibody libraries |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL236524A0 IL236524A0 (en) | 2015-02-26 |
| IL236524B true IL236524B (en) | 2019-01-31 |
Family
ID=49117845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL236524A IL236524B (en) | 2012-08-31 | 2014-12-31 | Camel antibody libraries |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10040870B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2890709A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6283030B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN104583236A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2013310839B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2879834A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL236524B (cg-RX-API-DMAC7.html) |
| IN (1) | IN2015DN00138A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014033304A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10202002131PA (en) | 2015-05-21 | 2020-05-28 | Harpoon Therapeutics Inc | Trispecific binding proteins and methods of use |
| US11623958B2 (en) | 2016-05-20 | 2023-04-11 | Harpoon Therapeutics, Inc. | Single chain variable fragment CD3 binding proteins |
| HUE072731T2 (hu) | 2016-05-20 | 2025-12-28 | Harpoon Therapeutics Inc | Egyszeres láncú variábilis fragmentumú CD3-kötõ proteinek |
| AU2017268460B2 (en) | 2016-05-20 | 2023-12-14 | Harpoon Therapeutics, Inc. | Single domain serum albumin binding protein |
| CA3030099A1 (en) | 2016-07-08 | 2018-01-11 | Staten Biotechnology B.V. | Anti-apoc3 antibodies and methods of use thereof |
| CA3044729A1 (en) | 2016-11-23 | 2018-05-31 | Harpoon Therapeutics, Inc. | Psma targeting trispecific proteins and methods of use |
| KR20210087108A (ko) | 2016-11-23 | 2021-07-09 | 하푼 테라퓨틱스, 인크. | 전립선 특이 막 항원 결합 단백질 |
| CN110139952B (zh) * | 2016-12-09 | 2022-11-25 | 深圳华大生命科学研究院 | 骆驼科抗体可变区免疫组库构建的引物组合及应用 |
| US11535668B2 (en) | 2017-02-28 | 2022-12-27 | Harpoon Therapeutics, Inc. | Inducible monovalent antigen binding protein |
| WO2018193427A1 (en) | 2017-04-21 | 2018-10-25 | Staten Biotechnology B.V. | Anti-apoc3 antibodies and methods of use thereof |
| CN115028727A (zh) | 2017-05-12 | 2022-09-09 | 哈普恩治疗公司 | 靶向msln的三特异性蛋白质及使用方法 |
| WO2018209298A1 (en) | 2017-05-12 | 2018-11-15 | Harpoon Therapeutics, Inc. | Mesothelin binding proteins |
| IL315737A (en) | 2017-10-13 | 2024-11-01 | Harpoon Therapeutics Inc | B-cell maturation antigen-binding proteins |
| LT3694529T (lt) | 2017-10-13 | 2024-10-10 | Harpoon Therapeutics, Inc. | Trispecifiniai baltymai ir panaudojimo būdai |
| US10538583B2 (en) | 2017-10-31 | 2020-01-21 | Staten Biotechnology B.V. | Anti-APOC3 antibodies and compositions thereof |
| CN111315772A (zh) | 2017-10-31 | 2020-06-19 | 斯塔顿生物技术有限公司 | 抗apoc3抗体及其使用方法 |
| JP2021523192A (ja) | 2018-05-14 | 2021-09-02 | ハープーン セラピューティクス，インク． | 免疫グロブリン分子の条件的活性化のための結合部分 |
| WO2020061482A1 (en) | 2018-09-21 | 2020-03-26 | Harpoon Therapeutics, Inc. | Egfr binding proteins and methods of use |
| US10815311B2 (en) | 2018-09-25 | 2020-10-27 | Harpoon Therapeutics, Inc. | DLL3 binding proteins and methods of use |
| CN115768463A (zh) | 2020-02-21 | 2023-03-07 | 哈普恩治疗公司 | Flt3结合蛋白及使用方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9722131D0 (en) | 1997-10-20 | 1997-12-17 | Medical Res Council | Method |
| GB2461546B (en) * | 2008-07-02 | 2010-07-07 | Argen X Bv | Antigen binding polypeptides |
| US8444976B2 (en) | 2008-07-02 | 2013-05-21 | Argen-X B.V. | Antigen binding polypeptides |
| CA2762837C (en) * | 2009-05-20 | 2021-08-03 | Novimmune S.A. | Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variants |
| GB2476681B (en) * | 2010-01-04 | 2012-04-04 | Argen X Bv | Humanized camelid VH, VK and VL immunoglobulin domains |
-
2013
- 2013-09-02 CN CN201380044638.9A patent/CN104583236A/zh active Pending
- 2013-09-02 US US14/419,881 patent/US10040870B2/en active Active
- 2013-09-02 AU AU2013310839A patent/AU2013310839B2/en active Active
- 2013-09-02 CA CA2879834A patent/CA2879834A1/en not_active Abandoned
- 2013-09-02 EP EP13758830.7A patent/EP2890709A2/en not_active Withdrawn
- 2013-09-02 JP JP2015529046A patent/JP6283030B2/ja active Active
- 2013-09-02 WO PCT/EP2013/068110 patent/WO2014033304A2/en not_active Ceased
- 2013-09-02 IN IN138DEN2015 patent/IN2015DN00138A/en unknown
-
2014
- 2014-12-31 IL IL236524A patent/IL236524B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| IN2015DN00138A (cg-RX-API-DMAC7.html) | 2015-06-12 |
| US20150166680A1 (en) | 2015-06-18 |
| AU2013310839B2 (en) | 2017-06-01 |
| JP6283030B2 (ja) | 2018-02-21 |
| CN104583236A (zh) | 2015-04-29 |
| JP2015526495A (ja) | 2015-09-10 |
| US10040870B2 (en) | 2018-08-07 |
| AU2013310839A1 (en) | 2015-01-29 |
| CA2879834A1 (en) | 2014-03-06 |
| WO2014033304A3 (en) | 2014-05-01 |
| EP2890709A2 (en) | 2015-07-08 |
| WO2014033304A2 (en) | 2014-03-06 |
| IL236524A0 (en) | 2015-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL264558A (en) | Anti–il–23p19 antibodies | |
| IL236524B (en) | Camel antibody libraries | |
| IL259826A (en) | Anti-alphabetatisiar antibody | |
| ZA201407509B (en) | Anti-fcrn antibodies | |
| IL234942A0 (en) | A tau antibody of human origin | |
| ZA201407897B (en) | Protease-regulated antibodies | |
| LT2703486T (lt) | Anti-b7-h3 antikūnas | |
| ZA201409358B (en) | Anti-siglec- 15 antibodies | |
| ZA201407316B (en) | Anti-fgfr2 antibody | |
| SG11201504765VA (en) | Anti-h7cr antibodies | |
| ZA201407079B (en) | Cdr-modified anti-siglec-15 antibody | |
| GB201220242D0 (en) | Antibody | |
| EP2804876A4 (en) | NEW ANTIBODIES | |
| EP2811018A4 (en) | ANTI-BODY ANTI-sAPPß | |
| IL235188A0 (en) | Antibodies against c-pdgf | |
| GB201209584D0 (en) | Modified antibodies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |